Skip to main content
Springer Nature Link
Log in

High-Dose Sodium Selenite Can Induce Apoptosis of Lymphoma Cells in Adult Patients with Non-Hodgkin’s Lymphoma

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The present study was undertaken to explore the effect of administration of high doses of sodium selenite on the apoptosis of lymphoma cells in patients with non-Hodgkin’s lymphoma (NHL). Forty patients with newly diagnosed NHL were randomly divided into two groups. Group I received standard chemotherapy, whereas group II received adjuvant sodium selenite 0.2 mg kg−1 day−1 for 7 days in addition to chemotherapy. Flow cytometry was used for monitoring of lymphoma cells apoptosis at the time of diagnosis and after therapy in the two groups. Sodium selenite administration resulted in significant increase in percentage of apoptotic lymphoma cells after therapy in group II (78.9 ± 13.3% versus 58.9 ± 18.9%, p < 0.05). In addition, patients who received sodium selenite treatment demonstrated statistically significant increase in percentage of reduction of cervical and axillary lymphadenopathy, decrease in splenic size, and decreased percentage of bone marrow infiltration. Also, we found a statistically significant decrease in cardiac ejection fraction (CEF) in group I and no reduction in CEF in patients who received sodium selenite ‘group II’, denoting the cardioprotective effect of selenium. It is concluded that sodium selenite administration at the dosage and duration chosen has synergistic effect to chemotherapy in inducing apoptosis and, consequently, could improve clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Allan CB, Lacourciere GM, Stadtman TC (1999) Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr 19:1–16

    Article  PubMed  CAS  Google Scholar 

  2. Thomson CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58:391–402

    Article  PubMed  CAS  Google Scholar 

  3. Clark LC, Cantor KP, Allaway WH (1991) Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46:37–42

    PubMed  CAS  Google Scholar 

  4. Schrauzer GN, White DA, Schneider CJ (1977) Cancer mortality correlation studies—III: statistical associations with dietary selenium intakes. Bioinorg Chem 7:23–31

    Article  PubMed  CAS  Google Scholar 

  5. El-Bayoumy K (2001) The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123–139

    PubMed  CAS  Google Scholar 

  6. Clark LC, Combs GF Jr, Turnbull BW et al (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957–1963

    Article  PubMed  CAS  Google Scholar 

  7. Duffield-Lillico AJ, Dalkin BL, Reid ME et al (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91:608–612

    Article  PubMed  CAS  Google Scholar 

  8. Last K, Maharaj L, Perry J et al (2003) Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin’s lymphoma. J Clin Oncol 21:2335–2341

    Article  PubMed  Google Scholar 

  9. Asfour IA, Fayek M, Raouf S, Soliman M, Hegab HM, El-Desoky H, Saleh R, Moussa MAR (2007) The impact of high-dose sodium selenite therapy on Bcl-2 expression in adult non-Hodgkin’s lymphoma patients: correlation with response and survival. Biol Trace Elem Res 120(1–3):1–10 (Dec)

    Article  PubMed  CAS  Google Scholar 

  10. Asfour IA, El Shazly S, Fayek MH, Hegab HM, Raouf S, Moussa MAR (2006) Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin’s lymphoma patients. Biol Trace Elem Res 110(1):19–32 (April)

    Article  PubMed  CAS  Google Scholar 

  11. Lu J, Kaeck M, Jiang C, Wilson AC, Thompson HJ (1994) Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47:1531–1535

    Article  PubMed  CAS  Google Scholar 

  12. Kim T, Jung U, Cho DY, Chung AS (2001) Se-methylselenocys-teine induces apoptosis through caspase activation in HL-60 cells. Carcinogenesis 22:559–565

    Article  PubMed  CAS  Google Scholar 

  13. Cho DY, Jung U, Chung AS (1999) Induction of apoptosis by selenite and selenodiglutathione in HL-60 cells: correlation with cytotoxicity. Biochem Mol Biol Int 47:781–793

    PubMed  CAS  Google Scholar 

  14. Shen HM, Yang CF, Ong CN (1999) Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int J Cancer 81:820–828

    Article  PubMed  CAS  Google Scholar 

  15. Jiang XR, Macey MG, Lin HX, Newland AC (1992) The antileukemic effects and the mechanism of sodium selenite. Leuk Res 16(4):347–352

    Article  PubMed  CAS  Google Scholar 

  16. Wilson AC, Thompson HJ, Schedin PJ, Gibson NW, Ganther HE (1992) Effect of methylated form of selenium on cell viability and the induction of DNA strand breakage. Biochem Pharmacol 43:1137–1141

    Article  PubMed  CAS  Google Scholar 

  17. Lockwood K, Moesgaard S, Hanioka T, Folkers K (1994) Apparent partial remission of breast cancer in high-risk patients supplemented with nutritional antioxidants. Mol Aspect Med 15(Supple):231–240

    Article  Google Scholar 

  18. Asfour IA, El Koaly MN, Kachour KR, Fathy O (1996) Clinical utility of plasma selenium levels and glutathione peroxidase activity in the follow up of adult lymphoma patients, Egypt. J Hematol 21(Suppl.):477–497

    Google Scholar 

  19. Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C (1991) A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29(3):289–294 (Jun)

    PubMed  CAS  Google Scholar 

  20. Emlen W, Nieber J, Kadera R (1994) Accelerated in vitro apoptosis of lymphocytes in patients with SLE. J Immunol 152:3658–3691

    Google Scholar 

  21. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Thun MJ (2004) Cancer statistics. Cancer J Clin 54:8–29

    Article  Google Scholar 

  22. Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534

    Article  PubMed  CAS  Google Scholar 

  23. Rayman MP (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64(4):527–542 (Nov)

    Article  PubMed  CAS  Google Scholar 

  24. Combs GF Jr, Gray WP (1998) Chemopreventive agents: selenium. Pharmacol Ther 79:179–192

    Article  PubMed  CAS  Google Scholar 

  25. El-Bayoumy K, DeVita V, Hellman S, Rosenberg SA (1991) The role of selenium in cancer prevention. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology. 4th edn. Lippincott, Philadelphia, pp 1–15

    Google Scholar 

  26. Stadtman TC (1996) Selenocysteine. Annu Rev Biochem 65:83–100

    Article  PubMed  CAS  Google Scholar 

  27. Sinha R, Said TK, Medina D (1996) Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett 107:277–284

    Article  PubMed  CAS  Google Scholar 

  28. Lanfear J, Fleming J, Wu L, Webster G, Harrison PR (1994) The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium? Carcinogenesis 15:1387–1392

    Article  PubMed  CAS  Google Scholar 

  29. Pines J (1994) The cell cycle kinases. Semin. Cancer Biol 5:305–313

    PubMed  CAS  Google Scholar 

  30. Pines J (1995) Cyclins, CDKs and cancer. Semin Cancer Biol 6:63–72

    Article  PubMed  CAS  Google Scholar 

  31. Menter DG, Sabichi AL, Lippman SM (2000) Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9:1171–1182

    PubMed  CAS  Google Scholar 

  32. Zeng H (2002) Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr 132:674–679

    PubMed  CAS  Google Scholar 

  33. Ip C, Thompson HJ, Ganther HE (2000) Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev 9:49–54

    PubMed  CAS  Google Scholar 

  34. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462

    Article  PubMed  CAS  Google Scholar 

  35. Cryns V, Yuan J (1998) Proteases to die for. Genes Dev 12:1551–1570

    Article  PubMed  CAS  Google Scholar 

  36. Gopalakrishna R, Chen ZH, Gundimeda U (1997) Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: Its role in inhibition of tumor promotion. Arch Biochem Biophys 348:37–48

    Article  PubMed  CAS  Google Scholar 

  37. Spyrou G, Bjornstedt M, Kumar S, Holmgren A (1995) AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett 368:59–63

    Article  PubMed  CAS  Google Scholar 

  38. Adams J (2002) Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer. Curr Opin Chem Biol 6:493–500

    Article  PubMed  CAS  Google Scholar 

  39. Aggarwal BB (2004) Nuclear factor-nB: the enemy within. Cancer Cell 6:203–208

    Article  PubMed  CAS  Google Scholar 

  40. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P, Venuta S (2004) NF-nB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia 18:11–17

    Article  PubMed  CAS  Google Scholar 

  41. Nakanishi C, Toi M (2005) Nuclear factor-nB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5:297–309

    Article  PubMed  CAS  Google Scholar 

  42. Juliger S, Goenaga-Infante H, Lister TA, Fitzgibbon J, Joel PS (2007) Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-KB inhibition and the rapid generation of other selenium species. Cancer Res 67(22):10984–10992

    Article  PubMed  Google Scholar 

  43. Gopee VN, Johnson JV, Sharma PR (2004) Sodium selenite-induced apoptosis in murine B-lymphoma cells is associated with inhibition of protein kinase C-δ, nuclear factor-κB, and inhibitor of apoptosis protein toxicological. Science 78:204–214

    CAS  Google Scholar 

  44. Philchenkov A, Zavelevich M, Khranovskaya N, Surai P (2007) Comparative analysis of apoptosis induction by selenium compounds in human lymphoblastic leukemia MT-4 cells. Exp Oncol 29(4):257–261

    PubMed  CAS  Google Scholar 

  45. Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister TA, Joel S (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol 17:773–779

    Article  PubMed  CAS  Google Scholar 

  46. Xiang N, Zhao R, and Zhong W (2008) Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol. doi:10.1007/s00280-008-0745-3

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Clinical Hematology, Clinical Hematology Unit, Ain-Shams Faculty of Medicine, Ain-Shams University, Cairo, Egypt

    Inas A. Asfour, Nevine N. Moustafa, Hany M. Hegab & Omar M. Fathey

  2. Department of Community Medicine, Faculty of Medicine, Ain-Shams University, Cairo, Egypt

    Maha M. El-Tehewi

  3. Department of Clinical Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt

    Manal H. Ahmed

  4. Department of Pharmacology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt

    Mey A. Abdel-Sattar

Authors
  1. Inas A. Asfour
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Maha M. El-Tehewi
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Manal H. Ahmed
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Mey A. Abdel-Sattar
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Nevine N. Moustafa
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Hany M. Hegab
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Omar M. Fathey
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Hany M. Hegab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asfour, I.A., El-Tehewi, M.M., Ahmed, M.H. et al. High-Dose Sodium Selenite Can Induce Apoptosis of Lymphoma Cells in Adult Patients with Non-Hodgkin’s Lymphoma. Biol Trace Elem Res 127, 200–210 (2009). https://doi.org/10.1007/s12011-008-8240-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-008-8240-6

Keywords